Medications

New biomarker may guide best use of KRAS inhibitors in lung cancer

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was predictive of survival outcomes for patients with advanced KRAS G12C-mutated non-small cell lung cancer (NSCLC), ...

Oncology & Cancer

Wilms tumors: How genes and imprinting pave the way for cancer

A research team at the University of Würzburg has gained new insights into the development of kidney tumors in young children. These enable a better risk assessment and could form the basis for targeted screening and improved ...

Oncology & Cancer

Discovering new ways to recharge T-cells fighting cancer

A pair of recent studies from the laboratory of Bin Zhang, MD, Ph.D., the Johanna Dobe Professor of Cancer Immunology, have uncovered new details about critical biological processes that may help improve cancer treatments.

page 2 from 40